OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-AF27         View EO 12866 Meetings	Received Date: 04/11/2013
Title: Infant Formula: Current Good Manufacturing Practices; Quality Control Procedures; Notification Requirements; Records and Reports; and Quality Factors
Agency/Subagency: HHS / FDA	Stage: Final Rule
Concluded Action: Consistent with Change	Concluded Date: 12/20/2013
Legal Deadline: None	Economically Significant: No
Publication Date: 02/10/2014	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Yes	Small Entities Affected: Businesses
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: Yes	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected